Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of Pennsylvania
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Luis Montaner, The Wistar Institute
ClinicalTrials.gov Identifier:
NCT01935089
First received: August 27, 2013
Last updated: January 28, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)